As of now all these drugs, which are appetite suppressants, are being dosed as you'll be on them for your lifetime. Maybe the dosing will be reduced but that hasn't been studied.
Key takeaways. Ozempic, Wegovy and other GLP-1 medications work by suppressing appetite. A 2022 study found that after people stopped taking Wegovy, they regained two-thirds of the weight they'd lost on the drug.